Early Detection Research Network

Ovary

VCAN (CSPG2) was shown to localize to vascular-like structures in ovarian cancer but not in normal ovaries.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/190/219
Under Review
Three
VCAN, or CSPG2, was one of 13 genes out of 50 selected for further validation in PMID:21617380. Average expression of VCAN was significantly higher in epithelial ovarian cancer tumors than any other normal tissue tested.
bea1382f67914e358e51b23ba28e5676
no
no
Contents

There are currently no items in this folder.